Efficacy and Safety of Tocilizumab
Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (Clinical trial)
Did you know, that you can look up clinical trials on scleroderma on following sites:
For instance you can find following trial by Genentech:
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) [focuSSced]
Official title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis.
The company is looking to enroll 210 patients in the following countries: Argentina, Belgium, Brazil, Bulgaria, Canada, Croatia, Denmark, France, Germany, Greece, Hungary, Italy, Lithuania, Japan, Mexico, Netherlands, Poland, Portugal, Romania, South Africa, Spain, Switzerland, UK, and USA.
news & events
The Swedish member of FESCA got a second place award in Sweden.
Study on the impact on various diets that might impact symptoms in Scleroderma.
Article by doctor Susana Oliveira, graduated Hospital Assistant and Systemic Sclerosis Consulting Coordinator at the Professor Doutor Fernando Fonseca Hospital